{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:06:02Z","timestamp":1787162762016,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s12630-019-01320-z","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T14:26:11Z","timestamp":1551104771000},"page":"540-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Fatal awake malignant hyperthermia episodes in a family with malignant hyperthermia susceptibility: a case series","\u00c9pisodes fatals d\u2019hyperthermie maligne sans anesth\u00e9sie dans une famille souffrant desusceptibilit\u00e9 \u00e0 l\u2019hyperthermie maligne\u00a0: une s\u00e9rie de cas"],"prefix":"10.1007","volume":"66","author":[{"given":"Elena","family":"Zvaritch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kraeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Richer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0670-1516","authenticated-orcid":false,"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"1320_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","volume":"128","author":"S Riazi","year":"2018","unstructured":"Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the post-genomics era: new perspectives on an old concept. Anesthesiology 2018; 128: 168-80.","journal-title":"Anesthesiology"},{"key":"1320_CR2","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/ALN.0b013e318167aee2","volume":"108","author":"MG Larach","year":"2008","unstructured":"Larach MG, Brandom BW, Allen GC, Gronert GA, Lehman EB. Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States. Anesthesiology 2008; 108: 603-11.","journal-title":"Anesthesiology"},{"key":"1320_CR3","doi-asserted-by":"publisher","unstructured":"Jones PM, Allen BN, Cherry RA, et al. Association between known or strongly suspected malignant hyperthermia susceptibility and postoperative outcomes: an observational population-based study. Can J Anesth 2018; DOI: \n                    https:\/\/doi.org\/10.1007\/s12630-018-1250-8\n                    \n                  .","DOI":"10.1007\/s12630-018-1250-8"},{"key":"1320_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s12630-014-0227-5","volume":"61","author":"S Riazi","year":"2014","unstructured":"Riazi S, Kraeva N, Muldoon SM, et al. Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference. Can J Anesth 2014; 61: 1040-9.","journal-title":"Can J Anesth"},{"key":"1320_CR5","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0140-6736(98)03078-5","volume":"352","author":"M Denborough","year":"1998","unstructured":"Denborough M. Malignant hyperthermia. Lancet 1998; 352: 1131-6.","journal-title":"Lancet"},{"key":"1320_CR6","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/hmg\/9.10.1515","volume":"9","author":"RL Brown","year":"2000","unstructured":"Brown RL, Pollock AN, Couchman KG, et al. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree. Hum Mol Genet 2000; 9: 1515-24.","journal-title":"Hum Mol Genet"},{"key":"1320_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1213\/ANE.0b013e3182768f99","volume":"116","author":"WA Lavezzi","year":"2013","unstructured":"Lavezzi WA, Capacchione JF, Muldoon SM, et al. Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old. Anesth Analg 2013; 116: 420-3.","journal-title":"Anesth Analg"},{"key":"1320_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1213\/XAA.0000000000000043","volume":"3","author":"LE Potts","year":"2014","unstructured":"Potts LE, Longwell JJ, Bedocs P, et al. Improving awareness of nonanesthesia-related malignant hyperthermia presentations: a tale of two brothers. A A Case Rep 2014; 3: 23-6.","journal-title":"A A Case Rep"},{"key":"1320_CR9","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","volume":"23","author":"N Dlamini","year":"2013","unstructured":"Dlamini N, Voermans NC, Lillis S, et al. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscul Disord 2013; 23: 540-8.","journal-title":"Neuromuscul Disord"},{"key":"1320_CR10","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12630-017-0815-2","volume":"64","author":"B Butala","year":"2017","unstructured":"Butala B, Brandom B. Muscular body build and male sex are independently associated with malignant hyperthermia susceptibility. Can J Anesth 2017; 64: 396-401.","journal-title":"Can J Anesth"},{"key":"1320_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"MG Larach","year":"1994","unstructured":"Larach MG, Localio AR, Allen GC, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 1994; 80: 771-9.","journal-title":"Anesthesiology"},{"key":"1320_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","volume":"110","author":"MG Larach","year":"2010","unstructured":"Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006. Anesth Analg 2010; 110: 498-507.","journal-title":"Anesth Analg"},{"key":"1320_CR13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s12630-018-1108-0","volume":"65","author":"S Riazi","year":"2018","unstructured":"Riazi S, Kraeva N, Hopkins PM. Updated guide for the management of malignant hyperthermia. Can J Anesth 2018; 65: 709-21.","journal-title":"Can J Anesth"},{"key":"1320_CR14","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0140-6736(74)90105-6","volume":"2","author":"DW Wingard","year":"1974","unstructured":"Wingard DW. Letter: Malignant hyperthermia: a human stress syndrome? Lancet 1974; 2: 1450-1.","journal-title":"Lancet"},{"key":"1320_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1213\/00000539-198804000-00019","volume":"67","author":"BA Britt","year":"1988","unstructured":"Britt BA. Combined anesthetic- and stress-induced malignant hyperthermia in two offspring of malignant hyperthermic-susceptible parents. Anesth Analg 1988; 67: 393-9.","journal-title":"Anesth Analg"},{"key":"1320_CR16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jama.286.2.168","volume":"286","author":"JR Tobin","year":"2001","unstructured":"Tobin JR, Jason DR, Challa VR, Nelson TE, Sambuughin N. Malignant hyperthermia and apparent heat stroke. JAMA 2001; 286: 168-9.","journal-title":"JAMA"},{"key":"1320_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/ALN.0b013e3182320068","volume":"115","author":"L Groom","year":"2011","unstructured":"Groom L, Muldoon SM, Tang ZZ, et al. Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families. Anesthesiology 2011; 115: 938-45.","journal-title":"Anesthesiology"},{"key":"1320_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.2169\/internalmedicine.33.450","volume":"33","author":"Y Wakabayashi","year":"1994","unstructured":"Wakabayashi Y, Nakano T, Kikuno T, Ohwada T, Kikawada R. Massive rhabdomyolysis associated with influenza A infection. Intern Med 1994; 33: 450-3.","journal-title":"Intern Med"},{"key":"1320_CR19","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1001\/jama.2009.1582","volume":"302","author":"E Ayala","year":"2009","unstructured":"Ayala E, Kagawa FT, Wehner JH, Tam J, Upadhyay D. Rhabdomyolysis associated with 2009 influenza A(H1N1). JAMA 2009; 302: 1863-4.","journal-title":"JAMA"},{"key":"1320_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/imj.12498","volume":"44","author":"JP Molenaar","year":"2014","unstructured":"Molenaar JP, Voermans NC, van Hoeve BJ, et al. Fever-induced recurrent rhabdomyolysis due to a novel mutation in the ryanodine receptor type 1 gene. Intern Med J 2014; 44: 819-20.","journal-title":"Intern Med J"},{"key":"1320_CR21","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/ncomms2501","volume":"4","author":"L Kimlicka","year":"2013","unstructured":"Kimlicka L, Lau K, Tung CC, Van Petegem F. Disease mutations in the ryanodine receptor N-terminal region couple to a mobile intersubunit interface. Nat Commun 2013; 4: 1506.","journal-title":"Nat Commun"},{"key":"1320_CR22","doi-asserted-by":"publisher","first-page":"e0130606","DOI":"10.1371\/journal.pone.0130606","volume":"10","author":"T Murayama","year":"2015","unstructured":"Murayama T, Kurebayashi N, Yamazawa T, et al. Divergent activity profiles of type 1 ryanodine receptor channels carrying malignant hyperthermia and central core disease mutations in the amino-terminal region. PLoS One 2015; 10: e0130606.","journal-title":"PLoS One"},{"key":"1320_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s12630-017-0865-5","volume":"64","author":"N Kraeva","year":"2017","unstructured":"Kraeva N, Sapa A, Dowling JJ, Riazi S. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review. Can J Anesth 2017; 64: 736-43.","journal-title":"Can J Anesth"},{"key":"1320_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"T Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene\u2013a review of its pharmacology, therapeutic use and new developments. Anaesthesia 2004; 59: 364-73.","journal-title":"Anaesthesia"},{"key":"1320_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.nmd.2016.02.007","volume":"26","author":"AK Bamaga","year":"2016","unstructured":"Bamaga AK, Riazi S, Amburgey K, et al. Neuromuscular conditions associated with malignant hyperthermia in paediatric patients: a 25-year retrospective study. Neuromuscul Disord 2016; 26: 201-6.","journal-title":"Neuromuscul Disord"},{"key":"1320_CR26","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1111\/ene.13051","volume":"23","author":"RS Scalco","year":"2016","unstructured":"Scalco RS, Voermans NC, Piercy RJ, Jungbluth H, Quinlivan R. Dantrolene as a possible prophylactic treatment for RYR1-related rhabdomyolysis. Eur J Neurol 2016; 23: e56-7.","journal-title":"Eur J Neurol"},{"key":"1320_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/ALN.0000000000000732","volume":"123","author":"MA Timmins","year":"2015","unstructured":"Timmins MA, Rosenberg H, Larach MG, Sterling C, Kraeva N, Riazi S. Malignant hyperthermia testing in probands without adverse anesthetic reaction. Anesthesiology 2015; 123: 548-56.","journal-title":"Anesthesiology"},{"key":"1320_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0140-6736(92)90248-2","volume":"339","author":"AJ Larner","year":"1992","unstructured":"Larner AJ. Dantrolene for exertional heatstroke. Lancet 1992; 339: 182.","journal-title":"Lancet"},{"key":"1320_CR29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1365-2044.2012.07226.x","volume":"67","author":"T Russell","year":"2012","unstructured":"Russell T, Riazi S, Kraeva N, Steel AC, Hawryluck LA. Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. Anaesthesia 2012; 67: 1021-4.","journal-title":"Anaesthesia"},{"key":"1320_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","volume":"118","author":"S Riazi","year":"2014","unstructured":"Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg 2014; 118: 381-7.","journal-title":"Anesth Analg"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12630-019-01320-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-019-01320-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-019-01320-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T20:03:37Z","timestamp":1582056217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12630-019-01320-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1320"],"URL":"https:\/\/doi.org\/10.1007\/s12630-019-01320-z","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"5 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}